Fred Hutch Cancer Center — United States
Medicine · Health Sciences
27h-index2.1kcitations64works0.02yr avg
Accepting Students?
No reports yet. Know if this professor is taking students?
Research Topics
Hematopoietic Stem Cell Transplantation(32), Acute Myeloid Leukemia Research(12), Acute Lymphoblastic Leukemia research(11), Mesenchymal stem cell research(7), Chronic Lymphocytic Leukemia Research(6)
Publications64 total
Molecular diagnosis and clinical decisions in adult acute leukemia.
PubMed·1999· 25 cited
Introduction: emerging therapies for hematologic malignancies: antibodies, antisense, and cytokine approaches
PubMed·1999· 3 cited
Antibody-targeted therapy for myeloid leukemia.
PubMed·1999· 53 cited
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
PubMed·1997· 31 cited
Allogeneic stem cell transplantation for the treatment of hematologic malignancies: current indications and challenges.
PubMed·1997· 4 cited
Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL).
PubMed·1997· 58 cited
Allogeneic hematopoietic stem cell transplantation for acute leukemia.
PubMed·1997· 88 cited
Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia.
PubMed·1996· 43 cited
Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells.
PubMed·1996· 23 cited
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
PubMed·1996· 43 cited
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.
PubMed·1996· 131 cited
Progress in adult acute lymphoblastic leukemia.
PubMed·1996
Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation.
PubMed·1995· 60 cited
Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
PubMed·1995· 36 cited
Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia.
PubMed·1994· 41 cited
Hematopoietic effects and clinical uses of granulocyte-macrophage colony-stimulating factor and PIXY321.
PubMed·1994· 4 cited
Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.
PubMed·1994· 8 cited
Autologous bone marrow transplantation for acute lymphoblastic leukemia.
PubMed·1993· 35 cited
Indications for bone marrow transplantation (BMT) in the treatment of acute myeloid leukemia (AML).
PubMed·1993· 3 cited
What role for 15-deoxyspergualin in enhancing engraftment of unrelated, histoincompatible canine marrow grafts and preventing graft-versus-host disease?
PubMed·1993· 3 cited
page 1 of 4Next →
Frequent Co-authors
CD Buckner(27), Rainer Storb(19), Clift Ra(12), Petersen Fb(12), JE Sanders(11), Jack W. Singer(11), Thomas Ed(10), K Doney(10), Deeg Hj(8), Sullivan Km(7), JA Hansen(6), Bensinger Wi(6), Claudio Anasetti(5), A Fefer(4), Taner Demirer(4), K Lilleby(4), Jan‐Stephan Sanders(4), R Storb(4), Deeg Hj(4), R Storb(4)